Media not available due to technical recording problems. EVRS is very sorry for the inconvenience.
Purpose:
To describe the main reason for aflibercept prescription in the treatment of exudative age-related macular degeneration (AMD) during the initial weeks of availability of this drug in a clinical setting.
Patients and methods:
During the first 16 weeks of availability in France, four experienced practitioners in retinal disease...